This inventor holds 2 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Amadeite, Centre D'etude Et De Valorisation Des Algues-Ceva, Centre National De La Recherche Scientifique. Active years: 2014-2025.
Company Filing History:
1 out of 4 
1 out of 1 
1 out of 5,383 
Years Active: 2014-2025
Title: Pi Nyvall-Collén: Innovator in Algal Extracts
Introduction
Pi Nyvall-Collén is a notable inventor based in Roscoff, France. He has made significant contributions to the field of biotechnology, particularly in the use of algal extracts for medical applications. His innovative work focuses on addressing post-traumatic immunosuppression, a critical area in healthcare.
Latest Patents
Nyvall-Collén holds a patent for an "Algal extract for use in the treatment or prevention of post-traumatic immunosuppression." This patent discloses an extract of algae from the order Ulvales, which includes sulfated and non-sulfated polyanionic polysaccharides. The molecular weight of these compounds is less than or equal to 50 kDa, making them suitable for preventing and treating complications associated with post-traumatic immunosuppression. He has 1 patent to his name.
Career Highlights
Throughout his career, Nyvall-Collén has worked with various companies, including Amadeite and Olmix. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of algal biotechnology.
Collaborations
He has collaborated with notable professionals such as Karim Asehnoune and Cédric Jacqueline. These partnerships have contributed to the advancement of his research and the successful application of his inventions.
Conclusion
Pi Nyvall-Collén is a pioneering inventor whose work with algal extracts has the potential to significantly impact the treatment of post-traumatic immunosuppression. His contributions to biotechnology highlight the importance of innovation in addressing complex medical challenges.